de la Chapelle A, Palomaki GE, Hampel H: Identifying Lynch syndrome. Int J Cancer, 125:1492-1493, 2009.

Lambert-Messerlian G, Palomaki GE, Canick JA: Adjustment of serum markers in first trimester screening. J Med Screen, 16:102-103, 2009.

Lambert-Messerlian G, Palomaki GE, Neveux LM, Chien E, Friedman A, Rosene-Montella K, Hayes M, Canick JA: Early onset preeclampsia and second trimester serum markers. Prenat Diagn, 29:1109-1117, 2009.

Marcos J, Craig WY, Palomaki GE, Kloza EM, Haddow JE, Roberson M, Bradley LA, Shackleton CHL: Maternal urine and serum steroid measurements to identify steroid sulftase deficiency (STSD) in second trimester pregnancies. Prenat Diagn, 29:771-780, 2009.

Palomaki GE, Lee JE, Canick JA, McDowell GA, Donnenfeld AE; for the ACMG Laboratory Quality Assurance Committee: Technical standards and guidelines: Prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements. Genet Med, 11:669-681, 2009.

Palomaki GE, Bradley LA, Douglas MP, Kolor K, Dotson DW: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review. Genet Med, 11:21-34, 2009.

Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN: EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med, 11:42-65, 2009.

Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med, 11:35-41, 2009.

Recommendations from the EGAPP Working Group: Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Genet Med, 11:15-20, 2009.

Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson DW, Doublas MP, Berg AO, Chair, on behalf of the EGAPP Working Group: The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP Working Group. Genet Med, 11:3-14, 2009.